Quest Biotechnology Inc said its newsubsidiary, Quest Blood Substitute Inc, signed the agreementand plan of merger with Hunt Research Corp and its affiliate,ICAS Corp.    It said Quest Blood expects to complete the merger withinthe next several weeks. Terms were not disclosed.    In a related transaction, Quest Blood said it executed anagreement with Alza Corp, which will make Alza a preferredshareholder of Quest Blood and offer Alza the right to acquirea total equity position of up to 25 pct of Quest Blood inexchange for acquisition of patent rights to Alza technology. Reuter&#3;